Gannex Pharma Co., Ltd. Report issue

For profit Phase 1 Phase 2
Founded: New York NY United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04686994
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Gannex Pharma Co., Ltd.